These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20644772)
1. Current directions in core-shell nanoparticle design. Schärtl W Nanoscale; 2010 Jun; 2(6):829-43. PubMed ID: 20644772 [TBL] [Abstract][Full Text] [Related]
2. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. Rosenholm JM; Sahlgren C; Lindén M Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166 [TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. Burns A; Ow H; Wiesner U Chem Soc Rev; 2006 Nov; 35(11):1028-42. PubMed ID: 17057833 [TBL] [Abstract][Full Text] [Related]
5. General route to multifunctional uniform yolk/mesoporous silica shell nanocapsules: a platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Zhang L; Wang T; Yang L; Liu C; Wang C; Liu H; Wang YA; Su Z Chemistry; 2012 Sep; 18(39):12512-21. PubMed ID: 22907903 [TBL] [Abstract][Full Text] [Related]
6. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug. Jang MK; Jeong YI; Nah JW Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624 [TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Mesoporous materials for drug delivery. Vallet-Regí M; Balas F; Arcos D Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012 [TBL] [Abstract][Full Text] [Related]
9. Facile strategy for synthesis of silica/polymer hybrid hollow nanoparticles with channels. Wu C; Wang X; Zhao L; Gao Y; Ma R; An Y; Shi L Langmuir; 2010 Dec; 26(23):18503-7. PubMed ID: 21062000 [TBL] [Abstract][Full Text] [Related]
10. Smart drug delivery through DNA/magnetic nanoparticle gates. Ruiz-Hernández E; Baeza A; Vallet-Regí M ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653 [TBL] [Abstract][Full Text] [Related]
11. Porous nanoparticles in drug delivery systems. Arayne MS; Sultana N Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130 [TBL] [Abstract][Full Text] [Related]
12. PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging. Pan J; Wan D; Gong J Chem Commun (Camb); 2011 Mar; 47(12):3442-4. PubMed ID: 21301716 [TBL] [Abstract][Full Text] [Related]
13. Mechanised nanoparticles for drug delivery. Cotí KK; Belowich ME; Liong M; Ambrogio MW; Lau YA; Khatib HA; Zink JI; Khashab NM; Stoddart JF Nanoscale; 2009 Oct; 1(1):16-39. PubMed ID: 20644858 [TBL] [Abstract][Full Text] [Related]
15. Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers. Zhu J; Tang A; Law LP; Feng M; Ho KM; Lee DK; Harris FW; Li P Bioconjug Chem; 2005; 16(1):139-46. PubMed ID: 15656585 [TBL] [Abstract][Full Text] [Related]
16. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
17. Clickable, biocompatible, and fluorescent hybrid nanoparticles for intracellular delivery and optical imaging. Müllner M; Schallon A; Walther A; Freitag R; Müller AH Biomacromolecules; 2010 Feb; 11(2):390-6. PubMed ID: 20025293 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxicity assessment of superparamagnetic iron-gold core-shell nanoparticles coated with polyglycerol. Jafari T; Simchi A; Khakpash N J Colloid Interface Sci; 2010 May; 345(1):64-71. PubMed ID: 20153479 [TBL] [Abstract][Full Text] [Related]
19. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Fadeel B; Garcia-Bennett AE Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional ruthenium(II) polypyridine complex-based core-shell magnetic silica nanocomposites: magnetism, luminescence, and electrochemiluminescence. Li MJ; Chen Z; Yam VW; Zu Y ACS Nano; 2008 May; 2(5):905-12. PubMed ID: 19206487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]